News | April 11, 2024
Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The company will respond to the Warning Letter within the stipulated timelines
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
Executes the first project for developing and manufacturing a novel anticancer mAb
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
A five-day inspection was concluded successfully with no critical and no major observations raised
Additional capacity broadens Grace’s fine chemical capabilities for API production
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
